Literature DB >> 24668076

Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma.

Alexander Kanellopoulos1, Katrina Koutsi, George Georgiou, Themis Ntalagiorgos, Kyriaki Petevi, George Boutsikas, Loula Papageorgiou, Gabriela Gainaru, Pagona Flevari, Maria K Angelopoulou, John Meletis, Theodoros P Vassilakopoulos.   

Abstract

Pure red cell aplasia (PRCA) is a rare cause of severe hypoplastic anemia characterized by profound depletion of erythroid precursors. Although PRCA may be associated with lymphoproliferative diseases, it has never been described in mantle cell lymphoma (MCL). We report what to our knowledge is the first case of a patient with indolent, non-nodal MCL complicated by PRCA. The patient presented with severe hypoproliferative anemia in the setting of a long-standing diagnosis of B-cell chronic lymphocytic leukemia. Bone marrow studies revealed the complete absence of erythroid progenitors. Cyclin D1 positivity on immunohistochemistry, confirmed by a positive FISH for t(11;14) (q13;q32), established the final diagnosis of MCL in conjunction with PRCA. Rituximab monotherapy led to rapid remission of splenomegaly and the leukemic picture, but the patient achieved transfusion independency only with subsequent administration of cyclosporine-A, and remained so during the subsequent 15 months despite the gradual disease recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668076     DOI: 10.1007/s12185-014-1563-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

1.  Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors.

Authors:  R Handgretinger; A Geiselhart; A Moris; R Grau; O Teuffel; W Bethge; L Kanz; P Fisch
Journal:  N Engl J Med       Date:  1999-01-28       Impact factor: 91.245

2.  Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.

Authors:  Martin Dreyling; Georg Lenz; Eva Hoster; Achiel Van Hoof; Christian Gisselbrecht; Rudolf Schmits; Bernd Metzner; Lorenz Truemper; Marcel Reiser; Hjalmar Steinhauer; Jean-Michel Boiron; Marc A Boogaerts; Ali Aldaoud; Vittorio Silingardi; Hanneke C Kluin-Nelemans; Joerg Hasford; Reza Parwaresch; Michael Unterhalt; Wolfgang Hiddemann
Journal:  Blood       Date:  2004-12-09       Impact factor: 22.113

3.  Treatment of older patients with mantle-cell lymphoma.

Authors:  H C Kluin-Nelemans; E Hoster; O Hermine; J Walewski; M Trneny; C H Geisler; S Stilgenbauer; C Thieblemont; U Vehling-Kaiser; J K Doorduijn; B Coiffier; R Forstpointner; H Tilly; L Kanz; P Feugier; M Szymczyk; M Hallek; S Kremers; G Lepeu; L Sanhes; J M Zijlstra; R Bouabdallah; P J Lugtenburg; M Macro; M Pfreundschuh; V Procházka; F Di Raimondo; V Ribrag; M Uppenkamp; M André; W Klapper; W Hiddemann; M Unterhalt; M H Dreyling
Journal:  N Engl J Med       Date:  2012-08-09       Impact factor: 91.245

4.  The splenic form of mantle cell lymphoma.

Authors:  Maria K Angelopoulou; Marina P Siakantariz; Theodoros P Vassilakopoulos; Flora N Kontopidou; George Z Rassidakis; Maria N Dimopoulou; Christos Kittas; Gerassimos A Pangalis
Journal:  Eur J Haematol       Date:  2002-01       Impact factor: 2.997

5.  A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.

Authors:  Jenny Orchard; Richard Garand; Zadie Davis; Gavin Babbage; Surinder Sahota; Estella Matutes; Daniel Catovsky; Peter W Thomas; Hervé Avet-Loiseau; David Oscier
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

Review 6.  Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.

Authors:  Alexander W Hauswirth; Cathrin Skrabs; Christian Schützinger; Alexander Gaiger; Klaus Lechner; Ulrich Jäger
Journal:  Leuk Lymphoma       Date:  2007-06

7.  Outcome of deferred initial therapy in mantle-cell lymphoma.

Authors:  Peter Martin; Amy Chadburn; Paul Christos; Karen Weil; Richard R Furman; Jia Ruan; Rebecca Elstrom; Ruben Niesvizky; Scott Ely; Maurizio Diliberto; Ari Melnick; Daniel M Knowles; Selina Chen-Kiang; Morton Coleman; John P Leonard
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

Review 8.  Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.

Authors:  Efthymia Vlachaki; Michael D Diamantidis; Philippos Klonizakis; Styliani Haralambidou-Vranitsa; Elizabeth Ioannidou-Papagiannaki; Ioannis Klonizakis
Journal:  ScientificWorldJournal       Date:  2012-04-19

9.  Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report.

Authors:  Athanasios Anastasiadis; Dimitrios Margaritis; Ioannis Kotsianidis; Emmanouil Spanoudakis; Anna Christoforidou; Ioannis Kostopoulos; Constantinos Tsatalas
Journal:  Cases J       Date:  2009-08-18

Review 10.  Autoimmune cytopenias in chronic lymphocytic leukemia.

Authors:  Giovanni D'Arena; Roberto Guariglia; Francesco La Rocca; Stefania Trino; Valentina Condelli; Laura De Martino; Vincenzo De Feo; Pellegrino Musto
Journal:  Clin Dev Immunol       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.